Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

People with male pattern baldness are more likely to have metabolic syndrome.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

Melatonin may help treat PCOS symptoms in rats.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

The conclusion is that there's no significant link between male pattern baldness and the severity of coronary artery disease.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Darkened knuckles can be an early sign of insulin resistance.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Many women with PCOS have hair loss, linked to age, hirsutism, sleep issues, and smoking.

Premature graying of hair is linked to vitamin D and B12 deficiencies, thyroid issues, iron imbalance, stress, and lifestyle habits, and affects quality of life.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.